Abstract Chronic granulomatous disease is a rare immunodeficiency due to defects in the phagocyte NADPH oxidase. The X-linked form (gp91 phox deficiency) accounts for about 70 % of cases; autosomal recessive p47 phox deficiency accounts for about 25 % of cases. We identified a 10 % incidence of diabetes in p47 phox deficient CGD, but none in X-linked CGD. Renal and cardiovascular diseases were also higher in p47 phox deficiency. p47 phox deficient CGD has noninfectious morbidities distinct from those in X-linked CGD.
Introduction
Chronic granulomatous disease (CGD) is a rare immunodeficiency caused by mutations in the subunits of the phagocyte NADPH oxidase; gp91 phox and p22 phox are membrane bound, while p47 phox , p40 phox , and p67 phox are cytosolic. Mutations in any of the five genes of the NADPH oxidase result in failure to produce superoxide and downstream antimicrobial oxidants leading to infections, granulomatous lesions, and hyperinflammation. Mutations in the X linked gp91
phox account for about 70 % of cases; autosomal recessive p47
phox deficiency causes about 25 % of cases, and the remainder are divided between p67 phox and p22 phox [1] . There is one reported case of p40 phox deficiency [2] . gp91
phox is most abundant in phagocytes while the other components are expressed in phagocytes and elsewhere, including vascular endothelium, the heart and renal epithelium [3] (Tables I and II) .
Overall survival in CGD is around 90 % stretching into early adulthood. Multiple factors influence this rate including age at diagnosis, history of infections, co-morbidities, and access to care. p47
phox CGD has a significantly better prognosis than X-linked disease [4, 5] . Infections and granuloma formation are less frequent and severe in p47 phox CGD, supposedly because they have higher residual superoxide production than those with X-linked CGD. Specific mutations in gp91 phox predict the presence or absence of residual phagocyte superoxide production and correlate strongly with overall survival [6] . In contrast, almost all patients with p47 phox deficiency have relatively high levels of residual superoxide production and good overall survival.
Despite the overall better survival in p47 phox deficient CGD, we recently recognized p47 phox deficient CGD patients with diabetes mellitus, with or without cardiovascular and renal disease. Having not seen similar events in X-linked CGD, we examined our entire population of CGD patients to understand the frequency of diabetes, renal and coronary artery disease.
Methods
Charts of all 229 CGD patients followed at the NIH were reviewed for CGD genotype, diabetes mellitus, insulin requirement, renal parameters, and symptomatic cardiovascular disease. Where available, laboratories, imaging and pathology were reviewed. All patients were consented to approved protocols of the National Institute of Allergy and Infectious Diseases.
Patient 1
A 17y African American girl was identified with p47
phox deficient CGD at age 3 through family screening. She had multiple pneumonias including Burkholderia cepacia, Trichosporin inkin [7] and Serratia marcesens; pancreatitis of unknown etiology which spontaneously resolved; hydradenitis suppurativa; and icthyosis vulgaris. At age 12, she was evaluated by endocrinology for weight 70.4 kg and acanthosis nigricans. Her hemoglobin A1C was 6.6 % (normal range 4.8-6.4), fasting glucose 90 mg/dL, glucose tolerance test within normal limits and low fasting insulin levels (32.4 uU/ml). She has been successfully managed with dietary modifications alone.
Patient 2
A 30 year old Caucasian woman was diagnosed with p47 phox deficient CGD as a child due to chronic otitis media. She had a brother with CGD who died at age 12 of Chromobacterium violaceum sepsis and a sister with CGD who is alive. She had multiple pneumonias including Mucor as well as cellulitis and colitis. Juvenile rheumatoid arthritis was diagnosed as a child and discoid lupus as an adult. At age 28, and weighing 60.2 kg, she presented with a hemoglobin A1C of 7.3 % (4.8-6.4). Her C-peptide was low at 0.2 ng/ml (0.9-7.1), pro-insulin was normal at 12 pmol/ml [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] , and insulin like growth factor was low at 76 ng/ml (117-329). Anti-islet, -insulin and, -GAD-65 antibodies were negative. Urine microalbumin/creatinine was normal at 8.1 ug/g (<17). She was started on metformin but required insulin replacement within a year. Complications of diabetes have included lower extremity neuropathy, and microalbuminuria with a microalbumin/creatinine 87.3 ug/g. An episode of diabetic ketoacidosis (DKA) around Mucor pneumonia led to complete right pneumonectomy, following which her diabetes has been more manageable.
Patient 3
Patient 3 is a 44 year old African American woman diagnosed with p47
phox deficient CGD at age 7 because of cervical lymphadenitis. Both of her siblings have p47 phox deficient CGD as well. She has had multiple pneumonias including Aspergillus and Burkholderia cepacia complex, as well as bronchiectasis, restrictive and obstructive lung disease, recurrent soft tissue abscesses, liver abscess, and osteomyelitis. She also has schizophrenia and hypertension. At age 30 weighing 79.9 kg, she developed insulin dependent diabetes. Eight years later she developed proteinuria with membranous features on kidney biopsy.
Patient 4
Patient 4, the twin sister of patient 3, was a 36 year old African American woman diagnosed with p47
phox deficient CGD at age 12 because of a liver abscess. She has had multiple pneumonias including Aspergillus, Nocardia, Burkholderia, and the dematiaceous mold, Wangiella; Staphylococcus aureus osteomyelitis; hydradenitis suppurativa; Actinomyces encephalitis; and recurrent skin abscesses. Hypertension and chronic renal failure were thought to be due to nephrotoxic antimicrobial exposure. At age 26 and weight 75.6 kg, she was diagnosed with type 2 diabetes mellitus with elevated blood glucose levels and HbA1C 10.6 %. Despite glyburide and dietary modification her diabetes was complicated by retinopathy. Dialysis began at age 29. At age 36 after 7 years of hemodialysis she developed fatal sepsis thought to be from her long-term central dialysis catheter.
Patient 5
Patient 5 is a 47 year old African American man diagnosed with p47
phox deficient CGD at age 29 because of Aspergillus pneumonia and staphylococcal osteomyelitis of the sternum requiring partial sternectomy. He is the brother of Patients 3 and 4. He has had fungal and bacterial pneumonias including Basidiomycete species and Staphylococcus aureus. At age 34 he developed renal insufficiency that progressed to end stage renal disease requiring hemodialysis. The etiology was presumed to be previous amphotericin B therapy for his fungal infections. At age 44 he underwent cadaveric kidney transplant, complicated by mild acute and chronic rejection and he remains on steroids, mycophenolate mofetil, and FK-506 for immunosuppression. Steroid induced diabetes has been managed with insulin. 
Patient 6
A 64 year old Caucasian man was diagnosed with CGD at age 38 because of Pseudomonas pneumonia complicated by respiratory failure with prolonged intubation and ventilatory support [8] . He had E. coli liver abscess as a younger man and mulch pneumonitis at 63 years (patient 5 in Siddiqui et al [9] ). He also had chronic icthyosis and MelkerssonRosenthal syndrome [8] . At age 31 he developed type 1 diabetes and required insulin within the year. Retinopathy and neuropathy were typical of diabetes. Multiple myocardial infarctions led to coronary artery bypass graft surgery of 5 vessels at age 55. He died at 64 years following his mulch pneumonitis with cardiac and renal failure.
Patient 7
A 46 year old Caucasian man was diagnosed with p47
phox deficient CGD at age 12 because of recurrent skin and soft tissue abscesses. He had smoked since age 9. He had multiple pneumonias and liver abscesses with multiple resections. Brain aneurysms were found as part of family screening. At age 43 he had an abnormal stress test and had stent placed in left anterior descending coronary artery. Another stent was placed subsequently in the distal circumflex coronary artery. At age 45 and weight 80 kg, he was diagnosed with diabetes and is now managed with glipizide, sitagliptin, and insulin.
Patient 8
A 27 year old Mexican man was diagnosed with p47 phox deficient CGD at age 25 because of Nocardia otitidiscalvarium osteomyelitis of the scapula that required extensive debridement and radical scapulectomy. A few years preceding his diagnosis, and before receiving any antimicrobials he developed hypertension that was difficult to control. He never received nephrotoxic agents. Renal biopsy showed focal segmental glomerulosclerosis.
Patient 9
Patient 9 was a 28 year old man diagnosed with p47 phox deficient CGD at 10 months due to Aspergillus and Nocardia pneumonias. He had Paecilomyces variottii pneumonia at age 12 requiring left pneumonectomy and recurrent Aspergillus fumigatus pneumonia, during both of which amphotericin B was given in high dose. Recurrent cellulitis, hydradenitis suppurativa, vancomycin resistant Enterococcus faecium, Saccharomyces cerevasiae subhepatic abscess, and aseptic meningitis were other complications. 
Results and Discussion
Of 64 patients with p47 phox deficient CGD followed at the National Institutes of Health, 6 (9.4 %) developed type 1-like diabetes mellitus and 5 (7.8 %) developed kidney disease, 3 of whom developed ESRD. Several developed severe cardiovascular disease, as well. Of the diabetic patients, 3 were mildly obese, 1 was overweight, and 2 were normal weight based on body mass index (BMI) criteria. All patients presented with diabetes at a relatively young age (ages 12-45), a feature more consistent with type 1 diabetes. The three patients with higher BMI's (30.1-32.7 kg/m 2 ) were the eldest at presentation and 2 had dyslipidemia, placing them at higher risk for metabolic syndrome and type 2 diabetes. However, 2 mildly obese and 2 normal BMI patients required insulin replacement within 6 months of diagnosis after failing insulin sparing medications. Diabetes was complicated by proteinuria in 3, neuropathy in 2, and retinopathy in 2. In contrast to the 9.4 % of p47 phox deficient patients with diabetes, none of the 165 patients with Xlinked CGD followed at the NIH have developed diabetes independent of specific mutation or residual superoxide production (p =0.0004). Approximately one third of Xlinked CGD patients followed at the NIH have missense mutations in CYBB allowing for low-level residual superoxide production similar to that seen in p47 phox deficiency [6] . Female carriers of X-linked CGD also have low level to normal levels of superoxide production based on degree of Lyonization. Diabetes had not occurred in any female carriers to the best of our knowledge, but we have not systematically explored this aspect of X-linked carriage. Also, no patients with other forms of autosomal recessive CGD (6  with p67 phox deficiency, 8 with p22 phox deficiency, and 1 with p40 phox deficiency) have developed diabetes. Renal pathology included membranous glomerulonephropathy, focal segmental glomerulosclerosis, and nephrocalcinosis. Four patients had received nephrotoxic agents and 2 have not developed end stage renal disease. Cardiovascular diseases include hypertension in 2, coronary artery disease in 2, and cerebral aneurysms in 1. One patient's coronary artery disease was complicated by fatal congestive heart failure. Two patients had severe vascular disease requiring extensive corrective surgery. Approximately 51 % of X linked and 42 % of p47 phox deficient patients had fungal infections that were treated to some degree with nephrotoxic agents. Fourteen (8.5 %) X linked CGD patients developed acute renal failure during their treatment and 4 (2.4 %) developed chronic renal failure that progressed to end stage renal disease. One p22 phox deficient patient developed chronic renal failure associated with nephrotoxic antimicrobial use. Two p47 phox deficient patients have developed acute renal failure and 3 have developed ESRD, 2 going on to receive kidney transplants. Despite equal frequency of nephrotoxic agent use in these two populations, a larger proportion of p47 phox deficient patients developed chronic kidney disease.
Of the 60 patients with CGD reported by Walther et al in 1962, 7 had elevated creatinine, 3 were X-linked, 3 were due to p47 phox deficiency, and 1 was due to p22 phox deficiency [11] . Amphotericin use was associated in 4 cases, ureteral obstruction in 2, and both in 1. Interestingly, obstructive lesions occurred nearly 8 times more frequently in those with X-linked than p47 phox deficient CGD, whereas renal insufficiency was equal between those with p47 phox deficiency and X-linked CGD [11] . Primary renal disorders also appear more common in p47 phox deficient than in X-linked CGD. Interstitial nephritis [11] [12] [13] , ESRD due to HenochSchonlein nephritis and associated 18q syndrome [14] , immune complex glomerulonephritis associated with staphylococcal liver abscess [11, 15] , FSGS [16, 10] , papillary necrosis [11, 16, 17] , nephrocalcinosis [10] , and renal amyloidosis [18] [19] [20] [21] have all been reported with most occurring in those with p47 phox deficiency [14] [15] [16] 22] . Renal transplant has also been successful in p47
phox deficient CGD patients with ESRD [10] .
Autoimmune disorders are relatively common in CGD. Discoid lupus is more common in X-linked female carriers [23] , while idiopathic thrombocytopenic purpura, juvenile idiopathic arthritis, autoimmune pulmonary disease, myasthenia gravis, IgA nephropathy, antiphospholipid syndrome, and recurrent pericardial effusions have also been reported [5, 24] . The p47
phox deficient CGD mouse model suggests that reactive oxygen species (ROS) are critical for the development of insulin-dependent diabetes, since CGD mice are protected [25] . In contrast, our patients with p47 phox deficiency and impaired superoxide production were much more prone to diabetes than either X-linked CGD patients or normals, suggesting markedly distinct roles for p47 phox in humans and mice.
Nuclear cytosolic factor 1 (NCF1) encodes p47 phox located on chromosome 7q11.23. The vast majority of mutations in NCF1 are due to the same homozygous mutation, a GT deletion (ΔGT) at the beginning of exon 2 causing a frame shift and premature stop codon at amino acid 51 [6, 26] . The ΔGT allele is the most common CGD-causing allele in the population, with a carrier frequency of 1:250. This high frequency is attributed to the two NCF1 pseudogenes carrying the ΔGT that flank the functional allele [27] . Recombination events between NCF1 and these pseudogenes lead to the incorporation of ΔGT into NCF1. It has also been shown that the pseudogenes are transcriptionally active, although their function, if any, is unclear [28] . It is theoretically possible that some of the manifestations of p47 phox -deficient CGD could in fact be due to aberrant expression of a pseudogene, but this possibility would be very difficult to explore.
Increased production of ROS has been viewed as contributing to multiple different cardiovascular diseases. Therefore, mutations in any of the subunits of the NADPH oxidase should theoretically be protective against development of cardiovascular disease. In agreement with this assumption, patients with CGD have been shown to have decreased platelet recruitment to agonist induced thrombus formation in vitro [29] and enhanced arterial dilation following induced sheer stress [30] with reduced injury following ischemia/reperfusion injury [31] in vivo. However, under physiologic conditions, ROS help regulate vascular tone and intracellular signaling pathways involving proliferation, migration, and differentiation. Although still abnormal, patients with p47 phox deficiency do have some residual superoxide production, which likely contributes to their improved survival as compared to those with X-linked CGD [6] . However, whether these low amounts of superoxide, which are higher than those in typical X-linked CGD, are both protective against CGD mortality while at the same time contributing to the development of diabetes and cardiovascular pathology, remains unclear.
Diabetes, renal and cardiovascular diseases occur more often and with greater severity in p47 phox deficient CGD than in gp91 phox deficient CGD, indicating distinct features to p47 phox CGD, likely beyond the generation of superoxide alone.
